Olpasiran
amgen
[]
#ocean(a)-dose at #aha2022: in a phase 2 rct of olpasiran (sirna against lp(a)) incl patients with cvd, olpasiran led to marked &gt;95% in lp(a), also reduced apob, ph3 trial to launch later this year 
Cardiologist + researcher @MGHHeartHealth. Preventive cardiology, women's health, pregnancy, health policy. Tweets are my own. He/him.